Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Diagnostic or test agent produces in vivo fluorescence
Patent
1996-05-13
1998-01-20
Kight, John
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Diagnostic or test agent produces in vivo fluorescence
424 944, 424 91, 424 165, 540 1, A61K 4900, G01N 3100, G01N 3348
Patent
active
057098450
ABSTRACT:
This invention provides functional dyes of the general formula: ##STR1## wherein R.sup.1, R.sup.2, and R.sup.5 may be the same or different and are selected from the group consisting of hydrogen, C.sub.1 -C.sub.10 alkyl, C.sub.1 -C.sub.10 alkoxyl, hydroxyl, C.sub.1 -C.sub.10 hydroxyalkyl, C.sub.1 -C.sub.10 alkoxyalkyl, C.sub.1 -C.sub.10 aryl, carboxyl, C.sub.1 -C.sub.10 carboxylalkyl, halogen, nitro, C.sub.1 -C.sub.10 alkoxycarbonyl, mercapto, C.sub.1 -C.sub.10 mercaptoalkyl, C.sub.1 -C.sub.10 alkylthio, sulfonate, and --(CH.sub.2).sub.m --N(R.sup.6)(R.sup.7) wherein R.sup.6 and R.sup.7 are independently hydrogen or C.sub.1 -C.sub.10 alkyl, C.sub.1 -C.sub.10 acyl, and R.sup.6 and R.sup.7 are capable of forming 5, 6, or 7 membered rings which may optionally be substituted with --O--, --NR.sup.8, or --S--; R.sup.3 and R.sup.4 may be the same or different and are selected from the group consisting of C.sub.1 -C.sub.10 alkyl, C.sub.1 -C.sub.10 hydroxyalkyl, C.sub.1 -C.sub.10 alkoxyalkyl, C.sub.1-C.sub.10 aryl, C.sub.1 -C.sub.10 carboxylalkyl, C.sub.1 -C.sub.10 alkyl sulfonate, mercapto alkyl and --(CH.sub.2).sub.m N(R.sup.6)(R.sup.7); W.sup.1 and W.sup.2 may be the same or different and are selected from the group consisting of --S--, --O--, --Se--, --Te--, --NR.sup.8 and C(R.sup.9)(R.sup.10); and m is about 0-10; R.sup.8 is hydrogen, C.sub.1 -C.sub.10 alkyl, C.sub.1 -C.sub.10 alkoxy, C.sub.1 -C.sub.10 mercaptoalkyl, hydroxyl, C.sub.1 -C.sub.10 hydroxyalkyl, C.sub.1 -C.sub.10 alkoxyalkyl, C.sub.1 -C.sub.10 aryl, C.sub.1 -C.sub.10 carboxylalkyl, C.sub.1 -C.sub.10 alkoxycarbonyl, C.sub.1 -C.sub.10 alkylthio, and --(CH.sub.2).sub.m --N(R.sup.6)(R.sup.7); R.sup.9 and R.sup.10 are independently hydrogen, C.sub.1 -C.sub.10 alkyl, C.sub.1 -C.sub.10 alkoxyl, C.sub.1 -C.sub.10 hydroxyalkyl, C.sub.1 -C.sub.10 alkoxyalkyl, C.sub.1 -C.sub.10 carboxyalkyl, C.sub.1 -C.sub.10 alkoxycarbonyl, and --(CH.sub.2).sub.m --N(R.sup.6)(R.sup.7); and A is selected from the group consisting of --(CH.sub.2).sub.m, --C(R.sup.9)(R.sup.10), --(CH.sub.2).sub.m --N(R.sup.6)(R.sup.7) --O--, --S--, or --NR.sup.8.
REFERENCES:
patent: 3655392 (1972-04-01), Fumia, Jr. et al.
patent: 3855210 (1974-12-01), Keller
Elwood (1973), J. Org. Chem., vol. 38, No. 14, pp. 2425-2430.
"Dyes Containing the Phenalene Ring System. I. Synthesis of Benzothiazole--Containing Dyes".
Elwood (1973), J. Org. Chem., vol. 38, No. 14, pp. 2430-2433.
"Dyes Containing the Phenalene Ring System. II. Electronic Spectra and their Correlations with Hucke 1 Molecular Orbital Theory".
Fung Ella Y.
Rajagopalan Raghavan
Guffey Wendell Ray
Jones Dameron
Kight John
Stierwalt Brian K.
LandOfFree
Tricyclic functional dyes for contrast enhancement in optical im does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic functional dyes for contrast enhancement in optical im, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic functional dyes for contrast enhancement in optical im will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-723276